Lv11
60 积分 2025-04-11 加入
Editorial: Unveiling new horizons for liver steatosis genetic variants beyond hepatocellular carcinoma diagnosis ‐ exploring the potential of HSD17B13 inhibition
1小时前
待确认
Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease
3小时前
已完结
Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis
10天前
已完结
Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201
18天前
已完结
基于异植瘤小鼠的抗肿瘤药PK/PD模型:历史回顾、研究进展与应用实践
24天前
已完结
Translational PK-PD/TD modeling of antitumor effects and peripheral neuropathy in gemcitabine and nab-paclitaxel chemotherapy from xenograft mice to patients for optimal dose and schedule
24天前
已完结
皖公网安备34019202002308
